Related references
Note: Only part of the references are listed.Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models
Jeong-Ki Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges
Sonia Messina et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Systemic nature of spinal muscular atrophy revealed by studying insurance claims
Scott L. Lipnick et al.
PLOS ONE (2019)
FIREFISH Part 1: 16-month safety and exploratory outcomes of risdiplam (RG7916) treatment in infants with type 1 spinal muscular atrophy
G. Baranello et al.
NEUROMUSCULAR DISORDERS (2019)
RAINBOWFISH: A study of risdiplam (RG7916) in newborns with pre-symptomatic spinal muscular atrophy (SMA)
E. Bertini et al.
NEUROMUSCULAR DISORDERS (2019)
Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
Tamara Dangouloff et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier
Stefan Sturm et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1
Omar Dabbous et al.
ADVANCES IN THERAPY (2019)
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
Eugenio Mercuri et al.
NEUROMUSCULAR DISORDERS (2018)
Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs
Agnes Poirier et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)
SPINAL MUSCULAR ATROPHY: DIAGNOSIS AND MANAGEMENT IN A NEW THERAPEUTIC ERA
W. David Arnold et al.
MUSCLE & NERVE (2015)
Observational study of spinal muscular atrophy type I and implications for clinical trials
Richard S. Finkel et al.
NEUROLOGY (2014)
Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy
Michelle A. Farrar et al.
JOURNAL OF PEDIATRICS (2013)
Prevalence and Risk Factors for Feeding and Swallowing Difficulties in Spinal Muscular Atrophy Types II and III
Yen-Shan Chen et al.
JOURNAL OF PEDIATRICS (2012)
Of SMN in mice and men: a therapeutic opportunity
Kathryn J. Swoboda
JOURNAL OF CLINICAL INVESTIGATION (2011)
Spinal muscular atrophy: Clinical classification and disease heterogeneity
Barry S. Russman
JOURNAL OF CHILD NEUROLOGY (2007)
Modern management of spinal muscular atrophy
Susan T. Iannaccone
JOURNAL OF CHILD NEUROLOGY (2007)
Population screening and cascade testing for carriers of SMA
Melanie Smith et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
Spinal muscular atrophy in the neonate
JA Markowitz et al.
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING (2004)
Share Paper
